相似文献
1
Gene therapy in cardiac arrhythmias.
Indian Pacing Electrophysiol J. 2006 Apr 1;6(2):111-8.
2
Molecular mechanisms of arrhythmias.
Rev Port Cardiol. 1998 Oct;17 Suppl 2:II41-6.
3
Cardiac Delayed Rectifier Potassium Channels in Health and Disease.
Card Electrophysiol Clin. 2016 Jun;8(2):307-22. doi: 10.1016/j.ccep.2016.01.004. Epub 2016 Apr 1.
4
Distinguishing properties of cells from the myocardial sleeves of the pulmonary veins: a comparison of normal and abnormal pacemakers.
Circ Arrhythm Electrophysiol. 2008 Apr;1(1):39-48. doi: 10.1161/CIRCEP.107.748467.
5
Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
J Electrocardiol. 2001;34 Suppl:177-81. doi: 10.1054/jelc.2001.28865.
6
Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling.
J Am Coll Cardiol. 1999 Apr;33(5):1231-7. doi: 10.1016/s0735-1097(99)00008-x.
7
The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments.
PLoS One. 2016 Nov 10;11(11):e0166041. doi: 10.1371/journal.pone.0166041. eCollection 2016.
8
Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
Ann Acad Med Singap. 1998 Mar;27(2):248-54.
9
Simulation study of cellular electric properties in heart failure.
Circ Res. 1998 Jun 15;82(11):1206-23. doi: 10.1161/01.res.82.11.1206.
10
Pharmacology of cardiac potassium channels.
Adv Pharmacol. 2010;59:93-134. doi: 10.1016/S1054-3589(10)59004-5.
本文引用的文献
1
Biological pacemakers.
Indian Pacing Electrophysiol J. 2006 Jan 1;6(1):1-5.
2
Bacteria in gene therapy: bactofection versus alternative gene therapy.
Gene Ther. 2006 Jan;13(2):101-5. doi: 10.1038/sj.gt.3302635.
3
Catecholaminergic polymorphic ventricular tachycardia.
Heart Rhythm. 2005 May;2(5):550-4. doi: 10.1016/j.hrthm.2005.01.024.
4
Tissue-specific targeting for cardiovascular gene transfer. Potential vectors and future challenges.
Curr Gene Ther. 2004 Dec;4(4):457-67. doi: 10.2174/1566523043346138.
5
Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation.
Circulation. 2004 Nov 9;110(19):3115-20. doi: 10.1161/01.CIR.0000147185.31974.BE. Epub 2004 Oct 25.
6
Recreating the biological pacemaker.
Anat Rec A Discov Mol Cell Evol Biol. 2004 Oct;280(2):1046-52. doi: 10.1002/ar.a.20073.
7
Genes, stem cells and biological pacemakers.
Cardiovasc Res. 2004 Oct 1;64(1):12-23. doi: 10.1016/j.cardiores.2004.05.012.
8
Creation of a genetic calcium channel blocker by targeted gem gene transfer in the heart.
Circ Res. 2004 Aug 20;95(4):398-405. doi: 10.1161/01.RES.0000138449.85324.c5. Epub 2004 Jul 8.
9
The potential of Na+/Ca2+ exchange blockers in the treatment of cardiac disease.
Expert Opin Investig Drugs. 2004 Jun;13(6):653-64. doi: 10.1517/13543784.13.6.653.
10
Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors.
Cardiovasc Res. 2004 Jun 1;62(3):500-8. doi: 10.1016/j.cardiores.2004.02.004.
Zotero 插件